Top compounds associated with response to MAP4K1


Feature Type Standardized
Nominal ANOVA
mRNA Rapamycin CTRPv2 pan-cancer AAC 0.26 9e-09
mRNA PD-0325901 CCLE pan-cancer AAC -0.39 2e-08
mRNA Nilotinib CTRPv2 pan-cancer AAC -0.26 7e-08
mRNA Axitinib GDSC1000 pan-cancer AAC -0.29 8e-08
mRNA AZ628 GDSC1000 pan-cancer AAC -0.37 1e-07
mRNA sirolimus:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.23 2e-07
mRNA TAE684 CTRPv2 pan-cancer AAC -0.23 5e-07
mRNA selumetinib:UNC0638 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.23 5e-07
mRNA KW-2449 CTRPv2 pan-cancer AAC -0.2 5e-07
mRNA selumetinib:BRD-A02303741 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.23 5e-07
Download CSV